Skip to content
WeighLab

Evidence review

Wegovy Pill: Dose, Cost & How It Differs From Rybelsus

The short answer

The Wegovy pill is oral semaglutide for weight loss, taken once daily on an empty stomach. It starts at 1.5 mg and steps up every 30 days to a 25 mg maintenance dose. Self-pay runs $149 a month at 1.5 mg, $199 at 4 mg, and $299 at 9 mg and 25 mg. Rybelsus is a diabetes-only tablet.

By The WeighLab Bench, Tools & Data Desk
Section index07

"Oral semaglutide" sounds like one product. It is legally three — Rybelsus, Ozempic tablets, and the Wegovy pill — sold at three different milligram strengths, for two different FDA-approved purposes, by the same manufacturer. Confusing Rybelsus with an oral Wegovy is the single most common mix-up in this category, and the prescribing information settles it precisely.

PartnerGrade A

CoreAge Rx

$99/mo sema · $149/mo tirz

Visit CoreAge Rx
Semaglutide
$99/mo
Tirzepatide
$149/mo
Coverage
All 50 states
Brand-name
Compounded only
Modeled / yr
$1,188

CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.

Read the full CoreAge Rx review →

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never moves the Index. See our disclosure.

Partner

Wellorithm

72/100
Semaglutide
$899/moBrand Wegovy; fine print ties the price to a 3-month plan paid upfront
Tirzepatide
$1,199/moBrand Zepbound; fine print ties the price to a 3-month plan paid upfront
Visit Wellorithm

Is Rybelsus the same as the Wegovy pill?

Per the combined FDA prescribing information for Rybelsus and Ozempic tablets, both are indicated "as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus" and to reduce cardiovascular risk in adults with type 2 diabetes at high risk — full stop. Neither carries a weight-management indication1. That has not stopped widespread off-label use for weight loss, but if you've heard someone call Rybelsus "the pill version of Wegovy," that's not what its own label says it's for. The label goes further with a detail that is easy to miss: Rybelsus and Ozempic tablets "are not substitutable on a mg-to-mg basis"1 — despite being the identical molecule for the identical indication, Rybelsus titrates 3 mg → 7 mg → 14 mg while Ozempic tablets titrate 1.5 mg → 4 mg → 9 mg, two different dosing ladders for the same drug under two different brand names.

What is the Wegovy pill, and what dose is it?

Wegovy tablets are a separate, newer formulation with the indication Rybelsus lacks: weight reduction and cardiovascular risk reduction in adults with obesity or overweight, on the same combined label as Wegovy's injection2. It follows Wegovy injection's own brand split — Ozempic is the diabetes brand of injectable semaglutide, Wegovy the weight-management brand of the same molecule — mapped onto the oral form. The Wegovy tablet's titration starts at 1.5 mg once daily, climbs in a step-up schedule, and reaches a 25 mg once-daily maintenance dose2 — nearly double Rybelsus's 14 mg ceiling, because the two tablets are calibrated for different jobs, not different potencies of the same treatment.

How do you take the Wegovy pill?

Every oral semaglutide tablet, including the Wegovy pill, is built around SNAC (salcaprozate sodium), an absorption enhancer that lets a fraction of the peptide survive the stomach. That mechanism is why all three share the same non-negotiable instructions: take the tablet on an empty stomach with no more than 4 ounces of plain water, swallow it whole without splitting or crushing, and wait at least 30 minutes before eating, drinking anything else, or taking another oral medication13. Skip that window and less of the dose reaches circulation — a real pharmacokinetic constraint, not a suggestion. It is also why the injectable and oral versions are not simply interchangeable: switching between WEGOVY injection and WEGOVY tablets requires a specific protocol2, not a same-day swap.

What the trial evidence actually shows about oral dosing

The Wegovy tablet's 25 mg approved ceiling is not the highest dose that has been studied. In OASIS 1, a phase 3 trial of a 50 mg once-daily oral semaglutide dose — double today's approved maximum — patients lost significantly more weight than placebo over 68 weeks4, evidence that oral semaglutide's efficacy ceiling has room above the currently approved dose, similar in spirit to how Wegovy injection's own label permits up to 7.2 mg even though 2.4 mg is the commonly cited number. Oral bioavailability from SNAC-based absorption is inherently lower and more variable than a subcutaneous injection3, which is the pharmacological reason oral doses run so much higher in milligrams than their injectable counterparts for a comparable effect.

How much does the Wegovy pill cost at each dose?

The label moves you up one strength every 30 days, and Novo Nordisk's self-pay price changes with the strength. The doses below are the label's schedule2; the prices are the self-pay figures on Novo Nordisk's NovoCare Wegovy page, read in October 2026, where one month means one bottle of 30 tablets5.

Days on the label scheduleOnce-daily tablet doseSelf-pay price per month
1–30 (starting dose)1.5 mg$149
31–604 mg$199
61–909 mg$299
91 onward (maintenance)25 mg$299

At those prices, twelve 30-tablet bottles under the labeled progression would cost $3,338: one bottle each at $149, $199 and $299, then nine at $299. That supplies 360 tablets, not a complete 365-day year, and assumes unchanged prices and no treatment interruption. Visits, memberships and laboratory fees may be additional. The Wegovy pill cost guide explains the supply basis, commercial savings limits and Medicare Bridge questions. Self-pay eligibility and terms can change; confirm the figure for your prescribed strength before a fill. Our NovoCare Pharmacy review describes the service channel.

What do compounded oral tablets cost?

Brand Rybelsus and Ozempic tablets go through the same cash-pay and insurance channels as their injectable siblings; see what a GLP-1 costs without insurance for the manufacturer self-pay routes. On the compounded side, several providers we track disclose real oral-tablet pricing rather than injection-only menus: Somi Health offers a compounded oral semaglutide tablet alongside its $135/mo injectable, and Mevo Health lists compounded oral tablets at $199/mo across all doses. Compounded oral tablets are not the FDA-reviewed SNAC formulation studied in the trials above, and — per several providers' own published cons — carry weaker efficacy data than injectable semaglutide, so verify the pharmacy the same way you would for any compounded product before choosing pills over the needle on price alone. A structurally different oral option worth knowing about, if needles are the deciding factor: LillyDirect's Foundayo, a non-peptide oral GLP-1 that does not rely on SNAC or an empty-stomach window at all — see orforglipron, the drug behind that pill, for what the trial data actually shows and what it means that it isn't built on SNAC absorption.

The takeaway

If your prescriber writes "Rybelsus" or "Ozempic tablets," you are being treated for glycemic control at doses topping out at 14 mg or 9 mg; if it says "Wegovy tablets," you are on the weight-management product dosed up to 25 mg — and the two are not interchangeable pill-for-pill any more than Ozempic and Wegovy injections are. If you're choosing between the Wegovy pill and the weekly shot, Wegovy pill vs injection compares trial results, daily routines and price. Confirm which product and which indication your plan is actually built around, and price the real route — brand or verified compounded — against the full molecule comparison before assuming "oral" automatically means cheaper or weaker. The labels and trials behind this are indexed in our research library. Not medical advice — see our medical disclaimer and confirm your own prescription with your clinician.

Frequently asked questions

Is Rybelsus the same as the Wegovy pill?

No. Rybelsus and Ozempic tablets are FDA-approved only for glycemic control (and cardiovascular risk reduction) in type 2 diabetes, dosed up to 14 mg or 9 mg. Wegovy tablets are a separate, newer product approved for weight reduction, dosed up to 25 mg. All three are oral semaglutide, but they are not interchangeable.

Can I switch between Rybelsus and Ozempic tablets at the same dose?

No — the FDA label explicitly states Rybelsus and Ozempic tablets are not substitutable on a mg-to-mg basis, despite treating the same condition. They use different dosing ladders (3/7/14 mg vs 1.5/4/9 mg).

Why do oral semaglutide doses look so much higher than injection doses?

The oral tablets use an absorption enhancer (SNAC) to survive the stomach, but oral bioavailability is inherently lower and more variable than a subcutaneous injection, so the milligram doses are set much higher for a comparable effect.

References

  1. U.S. Food and Drug Administration (2026). RYBELSUS and OZEMPIC Tablets (oral semaglutide) Prescribing Information. DailyMed, U.S. National Library of Medicine. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98
  2. U.S. Food and Drug Administration (2026). WEGOVY (semaglutide) Injection and Tablets Prescribing Information. DailyMed, U.S. National Library of Medicine. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  3. Andersen A, Knop FK, Vilsbøll T (2021). A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes. Drugs. https://pubmed.ncbi.nlm.nih.gov/33964002/
  4. Knop FK, Aroda VR, do Vale RD, et al. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1). The Lancet. https://pubmed.ncbi.nlm.nih.gov/37385278/
  5. Novo Nordisk (2026). NovoCare Wegovy pricing page: self-pay price by tablet dose and list price (read October 2026). NovoCare, Novo Nordisk.
  6. U.S. government (2026). TrumpRx: medication prices, Wegovy pill. TrumpRx.gov. https://trumprx.gov/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.